Non-REM Sleep Arousal Disorder — Sleepwalking: Symptoms, Causes, Diagnosis & Treatment

Non-REM Sleep Arousal Disorder — Sleepwalking Type, clinically known as somnambulism, is a parasomnia characterized by repeated episodes of rising from bed and walking during sleep. These episodes typically occur during the first third of the night, when the deepest stages of non-rapid eye movement (NREM) sleep — specifically slow-wave sleep (stages N3) — are most concentrated.

During a sleepwalking episode, the individual exists in a dissociated state of consciousness: the brain is partially awake (enough to execute complex motor behaviors like walking, opening doors, or navigating stairs) yet simultaneously remains in deep sleep. The person typically has a blank, glassy-eyed stare, is relatively unresponsive to the efforts of others to communicate with them, and can be awakened only with considerable difficulty. Upon waking — whether during or after the episode — the individual usually has little to no memory of the event.

The DSM-5-TR classifies sleepwalking under Non-Rapid Eye Movement Sleep Arousal Disorders, alongside the Sleep Terror Type. Both conditions share the same underlying mechanism: an incomplete arousal from deep NREM sleep that produces complex behaviors without full conscious awareness. What distinguishes sleepwalking from sleep terrors is the predominance of ambulatory behavior rather than intense fear and autonomic activation, although overlap between the two presentations is common.

Sleepwalking is remarkably common in childhood. Epidemiological studies estimate that up to 29% of children between ages 2 and 13 have experienced at least one sleepwalking episode, with peak prevalence occurring around ages 10 to 13. The prevalence of regular, recurrent sleepwalking in children is estimated at approximately 5% to 8%. In adults, the estimated prevalence of current sleepwalking is approximately 1.5% to 4%, though up to 29% of adults may report a history of at least one episode across their lifetime. For the majority of children, sleepwalking resolves spontaneously by adolescence, but a meaningful minority carry the condition into adulthood, sometimes with increased complexity and risk.

The hallmark of sleepwalking is the act of getting out of bed and walking while still asleep, but the range of behaviors that can occur during episodes extends well beyond simple ambulation. Understanding the full spectrum of symptoms is essential for recognizing this disorder.

Core symptoms include:

• Rising from bed and walking during the first third of the sleep period — episodes typically emerge from deep slow-wave sleep, which is most abundant in the early hours of the night
• Blank, staring facial expression with open eyes — the individual appears awake but has a vacant, unfocused gaze
• Relative unresponsiveness — the person is difficult to communicate with and often does not acknowledge others
• Difficulty being awakened — vigorous efforts are usually required, and if the person is awakened during an episode, they typically appear confused and disoriented
• Amnesia for the event — upon full awakening (either during or the next morning), the individual has minimal or no recollection of the episode
• Rapid return to normal cognitive functioning — once fully awake, there is typically no prolonged period of confusion or impairment beyond the initial moments

Complex behaviors that can accompany sleepwalking:

• Opening and closing doors, navigating hallways and stairs
• Eating or preparing food (sometimes termed sleep-related eating disorder when prominent)
• Getting dressed or changing clothes
• Urinating in inappropriate places (e.g., closets)
• Talking or mumbling incoherently
• Attempting to leave the house or even operating a vehicle in rare, severe cases
• Engaging in sexual behavior during sleep (termed sexsomnia), which is a distinct and clinically significant variant

Warning signs that may indicate a problem beyond typical childhood sleepwalking include:

• Episodes that persist into adolescence or adulthood
• Increasing frequency or complexity of episodes
• Behaviors that pose a risk of injury to the individual or others
• Episodes accompanied by violent or aggressive behavior
• Significant daytime sleepiness or functional impairment
• New onset of sleepwalking in adulthood, which warrants thorough medical evaluation

Sleepwalking arises from a fundamental problem in the brain's management of the transition between deep sleep and wakefulness. Rather than fully awakening or remaining fully asleep, the brain enters a hybrid state in which motor systems and certain cortical areas activate while the regions responsible for conscious awareness, judgment, and memory formation remain dormant. Research using EEG (electroencephalography) during sleepwalking episodes consistently shows a characteristic pattern of simultaneous slow-wave (delta) activity in frontal regions and wake-like (alpha) activity in motor and cingulate cortex.

Genetic factors play a substantial role. Sleepwalking has a strong familial component:

• The risk of sleepwalking is approximately 10 times higher in first-degree relatives of affected individuals compared to the general population
• Twin studies show significantly higher concordance rates in monozygotic (identical) twins than in dizygotic (fraternal) twins
• Research has linked sleepwalking to the HLA-DQB1*05:01 allele and other genetic markers related to deep sleep regulation, though no single gene is responsible
• If both parents have a history of sleepwalking, the child's risk is substantially elevated — some estimates suggest up to 60% or higher

Predisposing and precipitating factors include:

• Age and neurodevelopment: Children have proportionally more slow-wave sleep than adults, which helps explain the high childhood prevalence. As the brain matures and slow-wave sleep naturally decreases, many children outgrow sleepwalking.
• Sleep deprivation: One of the most potent and well-documented triggers. Sleep loss increases the depth and proportion of slow-wave sleep during subsequent recovery sleep, creating conditions ripe for incomplete arousals.
• Irregular sleep schedules: Shift work, jet lag, and inconsistent bedtimes destabilize sleep architecture and increase vulnerability.
• Fever and illness: Particularly in children, febrile illness can provoke episodes.
• Stress and anxiety: Psychological stress is consistently identified as a trigger in both clinical and research settings.
• Medications: Certain drugs, including zolpidem, other sedative-hypnotics, lithium, antipsychotics, and antihistamines, have been associated with triggering or worsening sleepwalking.
• Alcohol consumption: Alcohol fragments sleep architecture and can precipitate episodes, particularly in genetically susceptible individuals.
• Other sleep disorders: Conditions that cause frequent arousals from deep sleep — especially obstructive sleep apnea (OSA) and periodic limb movement disorder (PLMD) — can trigger sleepwalking episodes. Treating these underlying conditions sometimes resolves the sleepwalking entirely.
• Environmental stimuli: Noise, light changes, a full bladder, or being touched during deep sleep can provoke an incomplete arousal.

The diagnosis of Non-REM Sleep Arousal Disorder — Sleepwalking Type is primarily clinical, based on a thorough history and the exclusion of other conditions. According to the DSM-5-TR, the diagnostic criteria require:

• Recurrent episodes of incomplete awakening from sleep, usually occurring during the first third of the major sleep episode, accompanied by sleepwalking
• Relative unresponsiveness during the episode — the individual is difficult to awaken and has a blank, staring expression
• Limited or absent dream imagery recalled upon awakening (distinguishing it from REM-related parasomnias)
• Amnesia for the episode
• The disturbance causes clinically significant distress or impairment in social, occupational, or other important areas of functioning
• The disturbance is not attributable to the physiological effects of a substance (medication or drug of abuse)
• The episodes are not better explained by another mental disorder or medical condition

Diagnostic evaluation typically includes:

• Detailed clinical interview: The clinician gathers a comprehensive sleep history, including descriptions of the episodes (often provided by a bed partner or family member), their timing within the night, frequency, duration, associated behaviors, potential triggers, and any family history of parasomnias.
• Sleep diary or actigraphy: Patients may be asked to keep a sleep log tracking bedtimes, wake times, and episodes over several weeks. Actigraphy (a wrist-worn motion sensor) can supplement self-report data.
• Polysomnography (PSG): An overnight sleep study in a laboratory is not required for routine cases but is recommended when the diagnosis is uncertain, when episodes are frequent or violent, when there is concern for another sleep disorder (such as obstructive sleep apnea or REM sleep behavior disorder), or when the onset is in adulthood. PSG can capture events in real time and demonstrate the characteristic emergence of complex behavior from slow-wave sleep, along with the distinctive hypersynchronous delta activity on EEG that often precedes episodes.
• Video-polysomnography: The gold standard for capturing and characterizing parasomnia episodes. It combines standard PSG with synchronized video and audio recording, allowing clinicians to correlate behavior with sleep stage.
• Neurological and medical evaluation: New-onset sleepwalking in adults warrants evaluation for underlying causes, including sleep apnea, nocturnal seizures, medication effects, and, rarely, neurodegenerative conditions. EEG may be indicated to rule out nocturnal frontal lobe epilepsy, which can mimic sleepwalking.

Key differential diagnoses include:

• REM sleep behavior disorder (RBD): Occurs during REM sleep (typically later in the night), involves dream-enacting behavior, and the individual often recalls vivid dream content — in contrast to the amnesia of sleepwalking
• Nocturnal frontal lobe epilepsy: Can produce bizarre nocturnal behaviors that superficially resemble sleepwalking but are seizure-driven
• Sleep-related dissociative disorder: A psychiatric condition in which dissociative episodes occur during the transition to or from sleep
• Obstructive sleep apnea with confusional arousals: Apneic events can fragment sleep and trigger parasomnia-like arousals

Treatment for sleepwalking is guided by the frequency and severity of episodes, the degree of risk to the individual or others, and the presence of identifiable triggers or comorbid conditions. For many people — particularly children with infrequent, uncomplicated episodes — reassurance and safety measures are sufficient. For others, more active intervention is warranted.

1. Safety Measures and Environmental Modifications

Regardless of severity, safety precautions are the foundation of management:

• Lock windows and exterior doors; consider door alarms or motion sensors
• Remove sharp objects, trip hazards, and obstacles from the bedroom and pathways
• Sleep on the ground floor when possible
• Install gates at the top of stairs
• Secure firearms and potentially dangerous items
• Do not sleep in bunk beds

2. Sleep Hygiene and Trigger Management

Because sleepwalking episodes are so strongly influenced by modifiable factors, behavioral interventions focused on sleep quality are a critical first-line approach:

• Maintain a consistent sleep schedule with adequate total sleep time — sleep deprivation is one of the most reliable triggers
• Avoid alcohol, particularly in the hours before bedtime
• Review medications with a prescriber — certain sedatives, hypnotics, and psychotropic medications can provoke episodes
• Manage stress through evidence-based strategies such as cognitive-behavioral therapy, relaxation training, or mindfulness-based approaches
• Treat comorbid sleep disorders — successful treatment of obstructive sleep apnea with CPAP (continuous positive airway pressure), for example, can significantly reduce or eliminate sleepwalking episodes

3. Scheduled Awakenings

This behavioral technique, primarily used with children, involves briefly waking the individual 15 to 30 minutes before the time episodes typically occur. The rationale is to disrupt the deep sleep cycle before an incomplete arousal can take place. Research supports this approach as effective in reducing episode frequency when applied consistently, and it is particularly useful for children with predictably timed episodes.

4. Psychotherapy

Cognitive-behavioral therapy (CBT) and hypnotherapy have demonstrated effectiveness in some patients, particularly adults with chronic sleepwalking. Clinical hypnosis (hypnotherapy), delivered by a trained professional, has shown positive results in case series and small controlled studies, with some patients maintaining remission for extended periods. CBT techniques focused on stress management and relaxation may also be beneficial, particularly when psychological stress is an identified trigger.

5. Pharmacotherapy

Medication is generally reserved for cases where episodes are frequent, dangerous, or significantly distressing, and where behavioral interventions have proven insufficient:

• Benzodiazepines: Low-dose clonazepam (typically 0.25–2 mg at bedtime) is the most widely studied and commonly used pharmacological intervention. It is thought to work by suppressing slow-wave sleep arousals and increasing the arousal threshold. Research and clinical experience support its efficacy, though it carries risks of dependence, daytime sedation, and potential worsening of obstructive sleep apnea.
• Antidepressants: Low-dose paroxetine, trazodone, and other serotonergic agents have shown benefit in some case reports and small studies, though the evidence base is less robust than for clonazepam.
• Melatonin: Emerging evidence suggests melatonin may reduce sleepwalking episodes in some individuals, possibly by modifying sleep architecture. It has a favorable side-effect profile and is sometimes tried before benzodiazepines.

The decision to use medication should involve a careful discussion between the patient (or caregivers) and a sleep medicine specialist or psychiatrist about risks, benefits, and the expected duration of treatment.

The prognosis for sleepwalking is generally favorable, particularly when it begins in childhood. The majority of childhood sleepwalking resolves spontaneously by mid-adolescence as the proportion of slow-wave sleep naturally declines with brain maturation. Studies suggest that approximately 75% to 80% of children who sleepwalk will stop experiencing regular episodes by the time they reach their teenage years.

However, several factors are associated with persistence into adulthood:

• Earlier onset in childhood
• Higher frequency of childhood episodes
• Strong family history of parasomnias
• Co-occurring sleep terrors
• Comorbid psychiatric conditions, particularly anxiety and mood disorders

For adults with chronic sleepwalking, the condition tends to have a waxing and waning course. Episodes may become more frequent during periods of stress, sleep deprivation, or illness and may subside during periods of stability. Complete spontaneous resolution in adults is possible but less predictable than in children.

With appropriate management — including trigger identification, sleep hygiene optimization, treatment of comorbid sleep disorders, and pharmacotherapy when indicated — most adults with sleepwalking achieve significant reduction in episode frequency and severity. The primary ongoing concern for all age groups is the risk of injury during episodes, which underscores the importance of sustained environmental safety measures even during periods of apparent remission.

Notably, adult-onset sleepwalking (beginning after age 18 with no prior history) is atypical and warrants thorough evaluation, as it may indicate an underlying neurological condition, medication effect, or another sleep disorder.

Sleepwalking exists within a broader family of NREM parasomnias and shares features, mechanisms, and comorbidity patterns with several other conditions:

• Sleep Terrors (Night Terrors): The other subtype of Non-REM Sleep Arousal Disorder. Sleep terrors also arise from slow-wave sleep and involve partial arousals with amnesia, but are dominated by intense fear, screaming, and autonomic activation (rapid heart rate, sweating, dilated pupils). Sleepwalking and sleep terrors frequently co-occur and share genetic predisposition.
• Confusional Arousals: Episodes of mental confusion during or following arousal from deep sleep, without the ambulatory component of sleepwalking. The individual may sit up in bed, appear disoriented, speak incoherently, or exhibit inappropriate behavior. This is considered part of the NREM parasomnia spectrum.
• REM Sleep Behavior Disorder (RBD): A parasomnia occurring during REM sleep in which the normal muscle atonia of REM is absent, allowing individuals to physically act out their dreams. Unlike sleepwalking, RBD occurs later in the night, is associated with vivid dream recall, and is more common in older adults. RBD is associated with neurodegenerative diseases such as Parkinson's disease and Lewy body dementia.
• Obstructive Sleep Apnea (OSA): OSA causes repeated arousals from sleep due to airway obstruction and is a well-documented trigger for NREM parasomnias, including sleepwalking. Treatment of OSA can resolve comorbid sleepwalking.
• Restless Legs Syndrome / Periodic Limb Movement Disorder: These conditions disrupt sleep continuity and may increase vulnerability to parasomnia events.
• Nightmare Disorder: While distinct from sleepwalking (nightmares occur during REM sleep and involve detailed, memorable dream content), the two conditions can co-occur and both fall under the broader category of sleep-wake disorders.
• Anxiety Disorders and PTSD: Stress and anxiety are both triggers for and common comorbidities with sleepwalking. Post-traumatic stress disorder (PTSD) is associated with various sleep disturbances including parasomnias.
• Nocturnal Frontal Lobe Epilepsy (NFLE): This seizure disorder produces episodic nocturnal behaviors that can closely mimic sleepwalking. Distinguishing between the two conditions sometimes requires video-EEG monitoring.

While occasional sleepwalking — especially in children — is common and typically benign, there are clear circumstances in which professional evaluation is strongly recommended:

• Episodes result in injury to the sleepwalker or others, or there is a significant risk of injury based on the behaviors observed
• Episodes are frequent — occurring multiple times per week — or are increasing in frequency
• Episodes involve complex or potentially dangerous behaviors such as leaving the house, driving, cooking, or aggressive actions
• Sleepwalking persists beyond early adolescence or begins for the first time in adulthood
• Significant daytime consequences are present, including excessive sleepiness, impaired concentration, or emotional distress
• There is concern about another sleep disorder, such as obstructive sleep apnea, or a neurological condition
• The individual or family members experience significant anxiety, fear, or disruption related to the episodes
• A new medication has been started around the time sleepwalking began or worsened

The appropriate professionals to consult include sleep medicine specialists, neurologists, psychiatrists, or psychologists with expertise in sleep disorders. A primary care physician can provide initial evaluation and referral. For children, a pediatric sleep specialist or developmental pediatrician may be most appropriate.

Seeking professional evaluation does not mean something is seriously wrong — it means getting an accurate understanding of what is happening and ensuring the individual is safe. Early intervention, when warranted, can prevent injuries and significantly improve quality of life for both the affected individual and their household.